Specifically, alterations in a set of lysoPC, PC, phosphatidylethanolamine, and sphingomyelin subclasses correlated with RA activity (189)
Consult a nephrologist or primary care provider before use
Potential Risks Sub-therapeutic dosing may delay A1C control for diabetic patients
GLP-1s can also cause gastrointestinal issues such as nausea and vomiting, which may cause some people to discontinue use due to side effects before achieving their weight-loss goals
Anti-Aging Support May reduce oxidative damage associated with aging
Most of all, while sulfur treatment at 0.4 mg/L enhanced plant growth and metabolic activity, higher concentrations resulted in growth inhibition, indicating potential metabolic trade-offs and suggesting a dose-dependent effect